UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) (USD hedged) Q-acc

Register to Unlock Ratings
Performance History30/06/2024
Growth of 1,000 (GBP) Advanced Graph
UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) (USD hedged) Q-acc
Fund8.828.1-3.92.414.9
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
26/07/2024
 USD 253.55
Day Change 0.78%
Morningstar Category™ Other Equity
ISIN LU1059394939
Fund Size (Mil)
26/07/2024
 EUR 493.47
Share Class Size (Mil)
26/07/2024
 USD 18.74
Max Initial Charge 5.00%
Ongoing Charge
17/07/2024
  1.10%
Investment Objective: UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) (USD hedged) Q-acc
This actively managed sub-fund predominantly invests in equities, equity rights or other equity interests in companies domiciled or chiefly active in Europe. The UBS ESG consensus score is used to identify issuers/companies for the investment universe with strong environmental and social performance characteristics, or a strong sustainability profile.
Returns
Trailing Returns (GBP)26/07/2024
YTD12.71
3 Years Annualised7.05
5 Years Annualised9.00
10 Years Annualised12.22
12 Month Yield 0.00
Management
Manager Name
Start Date
Maximilian Anderl
23/07/2012
Jeremy Leung
01/04/2011
Inception Date
07/05/2014
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI Europe NR EUR-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) (USD hedged) Q-acc30/06/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock85.571.7183.86
Bond0.000.000.00
Property0.000.000.00
Cash64.4356.527.92
Other8.310.098.23
Top 5 Regions%
Eurozone83.10
Europe - ex Euro15.55
United States0.76
United Kingdom0.58
Europe - Emerging0.01
Top 5 Sectors%
Financial Services21.11
Healthcare17.37
Industrials11.93
Consumer Defensive10.28
Technology10.02
Top 5 HoldingsSector%
Novo Nordisk A/S Class BHealthcareHealthcare5.44
UBS (Irl) Inv Sel Eq Opp L/S € U-B4.86
ASML Holding NVTechnologyTechnology4.26
UBS (Irl) Inv Sel Eq Opp L/S I-B3.43
Tryg A/SFinancial ServicesFinancial Services3.11
UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) (USD hedged) Q-acc

Related

* This share class has performance data calculated prior to the inception date, 2014-05-07. This is based upon a simulated/extended track record, using the track record of UBS (Lux) ES Eurp Opp Uncons € ($H) Pacc (ISIN: LU0975313742), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures